世界のマルチプレックスアッセイ市場2022年~2026年

Technavioが発行した調査報告書(IRTNTR73462-22)
◆英語タイトル:Global Multiplex Assays Market 2022-2026
◆商品コード:IRTNTR73462-22
◆発行会社(リサーチ会社):Technavio
◆発行日:2022年5月17日
◆ページ数:約120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、 ヨーロッパ、 アジア、その他地域
◆産業分野:バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥337,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥405,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥540,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

テクナビオ社は、世界のマルチプレックスアッセイ市場規模が2022年から2026年まで年平均7.7%成長し、13.4億ドルに達すると予測しています。本調査レポートは、マルチプレックスアッセイの世界市場を調査対象とし、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、種類別(タンパク質マルチプレックスアッセイ、核酸マルチプレックスアッセイ、細胞ベースマルチプレックスアッセイ)分析、顧客状況、地域別状況、推進要因・課題・動向、企業状況、企業分析などの項目を掲載しております。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界のマルチプレックスアッセイ市場規模:種類別(タンパク質マルチプレックスアッセイ、核酸マルチプレックスアッセイ、細胞ベースマルチプレックスアッセイ)
・顧客状況
・地域別状況
・推進要因・課題・動向
・企業状況
・企業分析
【レポートの概要】

Global Multiplex Assays Market 2022-2026

Technavio has been monitoring the multiplex assays market and it is poised to grow by $ 1.34 bn during 2022-2026, accelerating at a CAGR of 7.7% during the forecast period. Our report on the multiplex assays market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by predictive and preventive medicine for early diagnosis and treatment, an increase in chronic diseases, and advancements in laboratory automation platforms.

The multiplex assays market analysis includes type segment and geographic landscape.
Technavio’s multiplex assays market is segmented as below:

By Type
• Protein multiplex assays
• Nucleic acid multiplex assays
• Cell-based multiplex assays

By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the launch of multiplex assay-based technologies as one of the prime reasons driving the multiplex assays market growth during the next few years. Also, emergence of new disease targets and increased usage of solid-phase magnetic beads for isolation and detection of biomolecules acts will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the multiplex assays market covers the following areas:
• Multiplex assays market sizing
• Multiplex assays market forecast
• Multiplex assays market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading multiplex assays market vendors that include Abcam plc, Agilent Technologies Inc., Antigenix America Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio-Techne Corp., Cayman Chemical Co., DiaSorin SpA, Enzo Biochem Inc., Illumina Inc., Merck KGaA, Meso Scale Diagnostics LLC, PerkinElmer Inc., Promega Corp., QIAGEN NV, Quanterix Corp., Randox Laboratories Ltd., Seegene Inc., Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc. Also, the multiplex assays market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/multiplex-assays-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

【レポートの目次】

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Incremental Growth
o Exhibit 07: Executive Summary – Data Table on Incremental Growth
o Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis – Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition – Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type – Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type – Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 Protein multiplex assays – Market size and forecast 2021-2026
o Exhibit 28: Chart on Protein multiplex assays – Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Protein multiplex assays – Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Protein multiplex assays – Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Protein multiplex assays – Year-over-year growth 2021-2026 (%)
o 5.4 Nucleic acid multiplex assays – Market size and forecast 2021-2026
o Exhibit 32: Chart on Nucleic acid multiplex assays – Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Nucleic acid multiplex assays – Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Nucleic acid multiplex assays – Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Nucleic acid multiplex assays – Year-over-year growth 2021-2026 (%)
o 5.5 Cell-based multiplex assays – Market size and forecast 2021-2026
o Exhibit 36: Chart on Cell-based multiplex assays – Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Cell-based multiplex assays – Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Cell-based multiplex assays – Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Cell-based multiplex assays – Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Type
o Exhibit 40: Market opportunity by Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America – Market size and forecast 2021-2026
o Exhibit 46: Chart on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America – Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America – Year-over-year growth 2021-2026 (%)
o 7.4 Europe – Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe – Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe – Year-over-year growth 2021-2026 (%)
o 7.5 Asia – Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia – Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia – Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o 7.7 US – Market size and forecast 2021-2026
o Exhibit 62: Chart on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US – Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US – Year-over-year growth 2021-2026 (%)
o 7.8 Germany – Market size and forecast 2021-2026
o Exhibit 66: Chart on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Germany – Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Germany – Year-over-year growth 2021-2026 (%)
o 7.9 UK – Market size and forecast 2021-2026
o Exhibit 70: Chart on UK – Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on UK – Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on UK – Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on UK – Year-over-year growth 2021-2026 (%)
o 7.10 China – Market size and forecast 2021-2026
o Exhibit 74: Chart on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on China – Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on China – Year-over-year growth 2021-2026 (%)
o 7.11 Canada – Market size and forecast 2021-2026
o Exhibit 78: Chart on Canada – Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Canada – Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Canada – Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 Abcam plc
o Exhibit 89: Abcam plc – Overview
o Exhibit 90: Abcam plc – Product / Service
o Exhibit 91: Abcam plc – Key news
o Exhibit 92: Abcam plc – Key offerings
o 10.4 Becton Dickinson and Co.
o Exhibit 93: Becton Dickinson and Co. – Overview
o Exhibit 94: Becton Dickinson and Co. – Business segments
o Exhibit 95: Becton Dickinson and Co. – Key news
o Exhibit 96: Becton Dickinson and Co. – Key offerings
o Exhibit 97: Becton Dickinson and Co. – Segment focus
o 10.5 Bio Rad Laboratories Inc.
o Exhibit 98: Bio Rad Laboratories Inc. – Overview
o Exhibit 99: Bio Rad Laboratories Inc. – Business segments
o Exhibit 100: Bio Rad Laboratories Inc. – Key news
o Exhibit 101: Bio Rad Laboratories Inc. – Key offerings
o Exhibit 102: Bio Rad Laboratories Inc. – Segment focus
o 10.6 Bio Techne Corp.
o Exhibit 103: Bio Techne Corp. – Overview
o Exhibit 104: Bio Techne Corp. – Business segments
o Exhibit 105: Bio Techne Corp. – Key news
o Exhibit 106: Bio Techne Corp. – Key offerings
o Exhibit 107: Bio Techne Corp. – Segment focus
o 10.7 DiaSorin SpA
o Exhibit 108: DiaSorin SpA – Overview
o Exhibit 109: DiaSorin SpA – Business segments
o Exhibit 110: DiaSorin SpA – Key news
o Exhibit 111: DiaSorin SpA – Key offerings
o Exhibit 112: DiaSorin SpA – Segment focus
o 10.8 Meso Scale Diagnostics LLC
o Exhibit 113: Meso Scale Diagnostics LLC – Overview
o Exhibit 114: Meso Scale Diagnostics LLC – Product / Service
o Exhibit 115: Meso Scale Diagnostics LLC – Key offerings
o 10.9 Promega Corp.
o Exhibit 116: Promega Corp. – Overview
o Exhibit 117: Promega Corp. – Product / Service
o Exhibit 118: Promega Corp. – Key offerings
o 10.10 QIAGEN NV
o Exhibit 119: QIAGEN NV – Overview
o Exhibit 120: QIAGEN NV – Product / Service
o Exhibit 121: QIAGEN NV – Key news
o Exhibit 122: QIAGEN NV – Key offerings
o 10.11 Seegene Inc.
o Exhibit 123: Seegene Inc. – Overview
o Exhibit 124: Seegene Inc. – Business segments
o Exhibit 125: Seegene Inc. – Key news
o Exhibit 126: Seegene Inc. – Key offerings
o Exhibit 127: Seegene Inc. – Segment focus
o 10.12 Thermo Fisher Scientific Inc.
o Exhibit 128: Thermo Fisher Scientific Inc. – Overview
o Exhibit 129: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 130: Thermo Fisher Scientific Inc. – Key news
o Exhibit 131: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 132: Thermo Fisher Scientific Inc. – Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 133: Inclusions checklist
o Exhibit 134: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 135: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 136: Research methodology
o Exhibit 137: Validation techniques employed for market sizing
o Exhibit 138: Information sources
o 11.5 List of abbreviations
o Exhibit 139: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Incremental Growth
Exhibits7: Executive Summary – Data Table on Incremental Growth
Exhibits8: Executive Summary – Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global – Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis – Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants – Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes – Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry – Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition – Five forces 2021 and 2026
Exhibits24: Chart on Type – Market share 2021-2026 (%)
Exhibits25: Data Table on Type – Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Protein multiplex assays – Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Protein multiplex assays – Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Protein multiplex assays – Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Protein multiplex assays – Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Nucleic acid multiplex assays – Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Nucleic acid multiplex assays – Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Nucleic acid multiplex assays – Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Nucleic acid multiplex assays – Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Cell-based multiplex assays – Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Cell-based multiplex assays – Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Cell-based multiplex assays – Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Cell-based multiplex assays – Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Type ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America – Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America – Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America – Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America – Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe – Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe – Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia – Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia – Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US – Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US – Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US – Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US – Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Germany – Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Germany – Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK – Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK – Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK – Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK – Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on China – Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on China – Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on China – Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on China – Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada – Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada – Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada – Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: Abcam plc – Overview
Exhibits90: Abcam plc – Product / Service
Exhibits91: Abcam plc – Key news
Exhibits92: Abcam plc – Key offerings
Exhibits93: Becton Dickinson and Co. – Overview
Exhibits94: Becton Dickinson and Co. – Business segments
Exhibits95: Becton Dickinson and Co. – Key news
Exhibits96: Becton Dickinson and Co. – Key offerings
Exhibits97: Becton Dickinson and Co. – Segment focus
Exhibits98: Bio Rad Laboratories Inc. – Overview
Exhibits99: Bio Rad Laboratories Inc. – Business segments
Exhibits100: Bio Rad Laboratories Inc. – Key news
Exhibits101: Bio Rad Laboratories Inc. – Key offerings
Exhibits102: Bio Rad Laboratories Inc. – Segment focus
Exhibits103: Bio Techne Corp. – Overview
Exhibits104: Bio Techne Corp. – Business segments
Exhibits105: Bio Techne Corp. – Key news
Exhibits106: Bio Techne Corp. – Key offerings
Exhibits107: Bio Techne Corp. – Segment focus
Exhibits108: DiaSorin SpA – Overview
Exhibits109: DiaSorin SpA – Business segments
Exhibits110: DiaSorin SpA – Key news
Exhibits111: DiaSorin SpA – Key offerings
Exhibits112: DiaSorin SpA – Segment focus
Exhibits113: Meso Scale Diagnostics LLC – Overview
Exhibits114: Meso Scale Diagnostics LLC – Product / Service
Exhibits115: Meso Scale Diagnostics LLC – Key offerings
Exhibits116: Promega Corp. – Overview
Exhibits117: Promega Corp. – Product / Service
Exhibits118: Promega Corp. – Key offerings
Exhibits119: QIAGEN NV – Overview
Exhibits120: QIAGEN NV – Product / Service
Exhibits121: QIAGEN NV – Key news
Exhibits122: QIAGEN NV – Key offerings
Exhibits123: Seegene Inc. – Overview
Exhibits124: Seegene Inc. – Business segments
Exhibits125: Seegene Inc. – Key news
Exhibits126: Seegene Inc. – Key offerings
Exhibits127: Seegene Inc. – Segment focus
Exhibits128: Thermo Fisher Scientific Inc. – Overview
Exhibits129: Thermo Fisher Scientific Inc. – Business segments
Exhibits130: Thermo Fisher Scientific Inc. – Key news
Exhibits131: Thermo Fisher Scientific Inc. – Key offerings
Exhibits132: Thermo Fisher Scientific Inc. – Segment focus
Exhibits133: Inclusions checklist
Exhibits134: Exclusions checklist
Exhibits135: Currency conversion rates for US$
Exhibits136: Research methodology
Exhibits137: Validation techniques employed for market sizing
Exhibits138: Information sources
Exhibits139: List of abbreviations



【掲載企業】

Abcam plc, Agilent Technologies Inc., Antigenix America Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Techne Corp., Cayman Chemical Co., DiaSorin SpA, Enzo Biochem Inc., Illumina Inc., Merck KGaA, Meso Scale Diagnostics LLC, PerkinElmer Inc., Promega Corp., QIAGEN NV, Quanterix Corp., Randox Laboratories Ltd., Seegene Inc., Siemens Healthcare GmbH, Thermo Fisher Scientific Inc.

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のマルチプレックスアッセイ市場2022年~2026年(Global Multiplex Assays Market 2022-2026)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆